Difference between revisions of "BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM patent applications published on July 25th, 2024"
Jump to navigation
Jump to search
Wikipatents (talk | contribs) |
Wikipatents (talk | contribs) (Creating a new page) |
||
Line 1: | Line 1: | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
==Patent applications for BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on July 25th, 2024== | ==Patent applications for BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on July 25th, 2024== | ||
Revision as of 07:49, 26 July 2024
Contents
- 1 Patent applications for BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on July 25th, 2024
- 1.1 PRODUCTION OF THERAPEUTIC MESENCHYMAL STEM CELL-DERIVED EXOSOMES (18559667)
- 1.2 DOUBLE SIDED CHIMERIC ANTIGEN RECEPTOR (CAR) ENGINEERED CELL MEMBRANE BASED DRUG DELIVERY SYSTEMS (18558882)
- 1.3 DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE (18566362)
- 1.4 INDANONE AND TETRALONEKETO OR HYDROXYL OXIMES AS CANCEL THERAPEUTICS (18558765)
- 1.5 FISSION PRODUCT TRAP FOR SALT PIPE AND PUMP SHAFT SEALS AND METHODS OF USE THEREOF (18157561)
Patent applications for BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on July 25th, 2024
PRODUCTION OF THERAPEUTIC MESENCHYMAL STEM CELL-DERIVED EXOSOMES (18559667)
Main Inventor
Frederick F. LANG
DOUBLE SIDED CHIMERIC ANTIGEN RECEPTOR (CAR) ENGINEERED CELL MEMBRANE BASED DRUG DELIVERY SYSTEMS (18558882)
Main Inventor
Kytai NGUYEN
DRUG-ELUTING TUBES FOR IMPROVED PATIENT CARE (18566362)
Main Inventor
Daniel Stromberg
INDANONE AND TETRALONEKETO OR HYDROXYL OXIMES AS CANCEL THERAPEUTICS (18558765)
Main Inventor
Stanton McHardy
FISSION PRODUCT TRAP FOR SALT PIPE AND PUMP SHAFT SEALS AND METHODS OF USE THEREOF (18157561)
Main Inventor
Timothy Head